Back to search results

Proactive TDM Versus Standard Use of Biologics in Psoriasis

Abroad (travel likely)RecruitingPHASE4

Conditions

Psoriasis Vulgaris

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • AZ Sint-Jan, Bruges, Belgium

    Contact: Study coordinator (Els Wittouck)
    Contact: Principal Investigator (Els Wittouck, Dr.)

  • CHU Saint-Pierre, Brussels, Belgium

    Contact: Study coordinator (Jonathan Krygier)
    Contact: Principal Investigator (Jonathan Krygier, Dr.)

  • UCL Saint-Luc, Brussels, Belgium

  • ULB Erasme, Brussels, Belgium

    Contact: Study coordinator (Farida Benhadou)
    Contact: Principal Investigator (Farida Benhadou, Dr.)

  • UZ Brussel, Brussels, Belgium

    Contact: Study coordinator (Jan Gutermuth)
    Contact: Principal Investigator (Valerie Reynaert, Prof.)

  • Grand Hôpital de Charleroi, Charleroi, Belgium

  • AZ Alma, Eeklo, Belgium

    Contact: Study coordinator (Soetkin Desmet, Dr.) · secr.dermato@azalma.be
    Contact: Principal Investigator (Soetkin Desmet, Dr.)

  • Dermatologiepraktijk huidziekten Geel, Geel, Belgium

    Contact: Study coordinator (Hugo Boonen, Dr.)
    Contact: Principal Investigator (Hugo Boonen, Dr.)

  • AZ Maria Middelares, Ghent, Belgium

    Contact: Study coordinator (Veerle Dhondt, Dr.)
    Contact: Principal Investigator (Veerle Dhondt, Dr.)

  • UZ Gent, Ghent, Belgium

    Contact: Study coordinator (Jo Lambert, Prof.)
    Contact: Principal Investigator (Jo Lambert, Prof.)

  • Clinique André Renard, Herstal, Belgium

  • Dermatologie Handelskaai, Kortrijk, Belgium

    Contact: Study coordinator (Erwin Suys, Dr.)
    Contact: Principal Investigator (Erwin Suys, Dr.)

  • UZ Leuven, Leuven, Belgium

    Contact: Study coordinator (Tom Hillary, Dr.)
    Contact: Principal Investigator (Tom Hillary, Dr.)

  • CHU Liège, Liège, Belgium

  • Dermatologie Maldegem, Maldegem, Belgium

    Contact: Study coordinator (Sven Lanssens, Dr.)
    Contact: Principal Investigator (Sven Lanssens, Dr.)
Study leads

  • Jo Lambert, Prof.

    Principal Investigator

    University Hospital, Ghent

View source on ClinicalTrials.gov(opens in a new tab)